6EB1 image
Deposition Date 2018-08-03
Release Date 2019-03-06
Last Version Date 2024-10-09
Entry Detail
PDB ID:
6EB1
Title:
HIV-1 Integrase Catalytic Core Domain Complexed with Allosteric Inhibitor (2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-phenylisoquinolin-4-yl]acetic acid
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Integrase
Gene (Uniprot):pol
Mutations:F185H
Chain IDs:A
Chain Length:183
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CAF A CYS modified residue
Ligand Molecules
Primary Citation
An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors.
ACS Med Chem Lett 10 215 220 (2019)
PMID: 30783506 DOI: 10.1021/acsmedchemlett.8b00633

Abstact

Allosteric HIV-1 integrase inhibitors (ALLINIs) are a new class of potential antiretroviral therapies with a unique mechanism of action and drug resistance profile. To further extend this class of inhibitors via a scaffold hopping approach, we have synthesized a series of analogues possessing an isoquinoline ring system. Lead compound 6l binds in the v-shaped pocket at the IN dimer interface and is highly selective for promoting higher-order multimerization of inactive IN over inhibiting IN-LEDGF/p75 binding. Importantly, 6l potently inhibited HIV-1NL4-3 (A128T IN), which confers marked resistance to archetypal quinoline-based ALLINIs. Thermal degradation studies indicated that at elevated temperatures the acetic acid side chain of specific isoquinoline derivatives undergo decarboxylation reactions. This reactivity has implications for the synthesis of various ALLINI analogues.

Legend

Protein

Chemical

Disease

Primary Citation of related structures